Page last updated: 2024-10-21

3-aminobenzamide and Malignant Melanoma

3-aminobenzamide has been researched along with Malignant Melanoma in 9 studies

Research

Studies (9)

Timeframe	Studies, this research(%)	All Research%
pre-1990	4 (44.44)	18.7374
1990's	2 (22.22)	18.2507
2000's	1 (11.11)	29.6817
2010's	2 (22.22)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boon, MH	1
Parsons, PG	1
Malorni, W	2
Rivabene, R	2
Straface, E	2
Rainaldi, G	2
Monti, D	2
Salvioli, S	1
Cossarizza, A	2
Franceschi, C	2
Capri, M	1
Lönn, U	3
Lönn, S	3
He, YJ	1
Liu, RH	1
Ning, CQ	1
Yu, NF	1
Bedikian, AY	1
Papadopoulos, NE	1
Kim, KB	1
Hwu, WJ	1
Homsi, J	1
Glass, MR	1
Cain, S	1
Rudewicz, P	1
Vernillet, L	1
Hwu, P	1
Toshimitsu, H	1
Yoshimoto, Y	1
Augustine, CK	1
Padussis, JC	1
Yoo, JS	1
Angelica Selim, M	1
Pruitt, SK	1
Friedman, HS	1
Ali-Osman, F	1
Tyler, DS	1

Reviews

1 review available for 3-aminobenzamide and Malignant Melanoma

Article	Year
[Research progresses of the PARP inhibitors for the treatment of cancer]. Yao xue xue bao = Acta pharmaceutica Sinica, 2013, Volume: 48, Issue:5 Topics: Animals; Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; DNA Repair; Drug Therapy, Combinat	2013

Trials

1 trial available for 3-aminobenzamide and Malignant Melanoma

Article	Year
A phase IB trial of intravenous INO-1001 plus oral temozolomide in subjects with unresectable stage-III or IV melanoma. Cancer investigation, 2009, Volume: 27, Issue:7 Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Ch	2009

Other Studies

7 other studies available for 3-aminobenzamide and Malignant Melanoma

Article	Year
Cyclophosphamide resistance developed in a human melanoma cell line. Cancer treatment reports, 1984, Volume: 68, Issue:10 Topics: Benzamides; Caffeine; Cell Line; Cross-Linking Reagents; Cyclophosphamide; Drug Resistance; Humans;	1984
3-Aminobenzamide protects cells from UV-B-induced apoptosis by acting on cytoskeleton and substrate adhesion. Biochemical and biophysical research communications, 1995, Feb-15, Volume: 207, Issue:2 Topics: Animals; Apoptosis; Benzamides; Cell Adhesion; Cell Line; Cells, Cultured; Cytoskeleton; Epithelium;	1995
3-Aminobenzamide induces cytoskeleton rearrangement in M14 melanoma cells. Biochemical and biophysical research communications, 1994, Jul-29, Volume: 202, Issue:2 Topics: Benzamides; Cell Division; Cytoskeleton; Humans; Melanoma; Microscopy, Electron, Scanning; Microscop	1994
Step-wise progression of mammalian 10-kb DNA replication intermediates to mature chromatin. European journal of biochemistry, 1988, Dec-01, Volume: 178, Issue:1 Topics: Benzamides; Cell Line; Chromatin; DNA Replication; DNA, Neoplasm; Endonucleases; Humans; Melanoma; P	1988
Accumulation of 10-kilobase DNA replication intermediates in cells treated with 3-aminobenzamide. Proceedings of the National Academy of Sciences of the United States of America, 1985, Volume: 82, Issue:1 Topics: Aphidicolin; Benzamides; Cell Line; Diterpenes; DNA Replication; DNA, Single-Stranded; Humans; Inter	1985
Inhibition of poly(ADP-ribose) synthetase potentiates cell dacarbazine cytotoxicity. Biochemical and biophysical research communications, 1987, Feb-13, Volume: 142, Issue:3 Topics: Antineoplastic Agents; Aphidicolin; Benzamides; Cell Line; Dacarbazine; Diterpenes; DNA; DNA Repair;	1987
Inhibition of poly(ADP-ribose) polymerase enhances the effect of chemotherapy in an animal model of regional therapy for the treatment of advanced extremity malignant melanoma. Annals of surgical oncology, 2010, Volume: 17, Issue:8 Topics: Alkylating Agents; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Dacarb	2010